Cargando…
Absolute quantification of cell-free microRNAs in cancer patients
The hypothesis to use microRNAs (miRNAs) circulating in the blood as cancer biomarkers was formulated some years ago based on promising initial results. After some exciting discoveries, however, it became evident that the accurate quantification of cell-free miRNAs was more challenging than expected...
Autores principales: | Ferracin, Manuela, Lupini, Laura, Salamon, Irene, Saccenti, Elena, Zanzi, Maria Vittoria, Rocchi, Andrea, Da Ros, Lucia, Zagatti, Barbara, Musa, Gentian, Bassi, Cristian, Mangolini, Alessandra, Cavallesco, Giorgio, Frassoldati, Antonio, Volpato, Stefano, Carcoforo, Paolo, Hollingsworth, Alan B., Negrini, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4546486/ https://www.ncbi.nlm.nih.gov/pubmed/26036630 |
Ejemplares similares
-
miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression
por: Ferracin, Manuela, et al.
Publicado: (2013) -
Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR
por: Mangolini, Alessandra, et al.
Publicado: (2015) -
miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs
por: Lupini, Laura, et al.
Publicado: (2013) -
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia
por: Ferracin, Manuela, et al.
Publicado: (2010) -
Genetic subclonal complexity and miR125a-5p down-regulatio identify a subset of patients with inferior outcome in low-ris CLL patients
por: Rigolin, Gian Matteo, et al.
Publicado: (2013)